-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Amrize, Raises Price Target to $57

Benzinga·01/08/2026 16:04:59
語音播報
UBS analyst Marcus Cole maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $53 to $57.